Listening to relaxing music is associated with lower levels of IL-6. For example, there’s evidence that relaxing music reduces heart rate, blood pressure, and muscle tension.Ī protein called interleukin-6⁶ (IL-6), which contributes to the body’s defense against illness or injury, increases in migraine patients during an attack. Reflexive brainstem responses may also play a role. We don’t fully understand why music produces therapeutic responses in some people, Still, research⁴ on the connections between music and the brain indicates that music can lessen pain, reduce stress hormones, reduce activity in parts of the nervous system linked to stress, and influence activity in certain parts of the brain that may be involved in migraines⁵. How does audio therapy work, and what’s the science behind it?
The first known reference to music therapy appeared in 1789³, so while it’s not a new concept, music therapy is gaining attention for its possible benefits as a therapy for migraines. Audio therapy uses various audio types, such as sounds, music, or spoken words, to potentially improve a person’s health or wellness. Music therapy is a type of audio therapy. Scientists not only continue to search for a cure for the primary headache disorder but also for treatments that may provide relief for the many people for whom existing migraine treatments aren’t working.Īlthough migraine-specific drugs and general pain relievers are effective in helping many people manage their migraines, researchers are investigating the concept of migraine music therapy and its potential role in alleviating migraine attack symptoms - and studies² indicate it may be worth a try, although more research is needed. The results supported the hypothesis that an external audio protocol of TBB was effective in reducing perceived pain severity for participants.A condition that affects more than 10%¹ of the global population (an estimated three times more women than men), migraine headaches have become a prominent topic in research. Although the TBB and the placebo interventions both reduced the pain scores, a post hoc Bonferroni correction that compared pairs of MPI scores found a 77% larger drop in the mean for the TBB intervention, from M=4.60 at pretest to M=2.74 at the end of both TBB periods than in the mean for the sham intervention, with a change from M=4.60 at pretest to M=4.17 at the end of both sham periods. The analysis indicated a large main effect for the TBB intervention in reducing perceived pain severity, P<.001 (F2,60=84.98, r=0.74). The analysis compared the average mean for pretest and first and second posttest scores. Using the West Haven-Yale Multidimensional Pain Inventory (MPI), potential changes in perceived severity of chronic pain were measured (1) at baseline (2) after the first test at 14 d, either TBB or sham intervention and (3) after the second test at 28 d-either TBB or sham intervention. Interviews were conducted either in person or telephonically with e-mail support. Participants listened to the interventions via a Web site on the Internet or via a compact disc. Both interventions lasted 14 successive days each, with some participants hearing the TBB intervention first and the sham intervention second and some hearing them in the reverse order. Participants listened to 2 recordings-one using TBB at 6 Hz (TBB intervention) and one using a placebo of a nonbinaural beat tone of 300 Hz (sham intervention) for 20 min daily. Thirty-six US adults with various types of chronic pain, and with a median age of 47 y, ranging in ages from 26-69 y, participated in the study. The study was conducted in Richmond, VA, USA, with participants recruited from the financial sector. An a priori analysis indicated a sample size of 28 participants was needed for a 2-way repeated-measures analysis of variance (ANOVA). The quantitative, experimental, repeated-measures crossover study compared the results of 2 interventions in 2 time-order sequences. The pilot study assessed the effects that an external, audio, neural stimulus of theta binaural beats (TBB) had on returning the brain neurosignature for chronic pain to homeostasis. According to the National Institutes of Health, in 2011, chronic pain affected from approximately 10% to >50% of the adult population in the United States, with a cost of $61 billion to US businesses annually.
0 kommentar(er)
